(lp0
S'BRIEF-Xtant Medical Holdings Inc says Q4 loss per share $0.31 Reuters - Mar 9, 2017 BRIEF-Xtant Medical Holdings Inc says Q4 loss per share $0.31. March 9 Xtant Medical Holdings Inc : * Xtant Medical reports record fourth quarter revenue of $24.5 million, 10% growth compared to prior year period.'
p1
aS"Xtant Medical Holdings, Inc.  Files An 8-K Results of Operations ... Market Exclusive - Mar 9, 2017 The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment.Xtant Medical Holdings'  CEO Carl O'Connell on Q4 2016 Results ... - Seeking AlphaXtant Medical Holdings Inc  Shares Down 9.9% on Disappointing Earnings - Chaffey Breeze"
p2
aS"XTNT Announces Preliminary Fourth Quarter and Full Year 2016 Revenue ... GlobeNewswire  - Jan 11, 2017 BELGRADE, Mont., Jan. 11, 2017  -- Xtant Medical Holdings, Inc. , a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today has pre-announced&nbsp;...Xtant Medical reports preliminary Q4 and FY16 results - Seeking AlphaIs Xtant Medical Holdings Inc's  85% ROE Good Enough When Compared To ... - Simply Wall St"
p3
aS"Is Xtant Medical Holdings Inc's  ROE Of 85% Sustainable? Simply Wall St - Mar 9, 2017 Xtant Medical Holdings Inc's  ROE of 85% over the past year stood above the industry average of 15.24%. Often called the 'mother of all ratios', Return on Equity tells you how much capital is created in percentage terms for the amount ...Zacks: Analysts Set $2.83 Price Target for Xtant Medical Holdings Inc  - Petro Global News 24"
p4
aS"News Xtant Medical Holdings Inc.XTNT Wall Street Journal - Feb 11, 2011 News Xtant Medical Holdings Inc.XTNT. Significant News Only. 02/22/17; Press Release. Xtant Medical Announces Appointment of Carl O'Connell to Permanent CEO."
p5
aS"Xtant Medical Holdings  Appoints Carl O'Connell as Permanent CEO StreetInsider.com - Feb 22, 2017 Xtant Medical Holdings, Inc.  today announced the appointment of Carl O'Connell as the permanent CEO, effective February 17th, 2017."
p6
aS'The Top Three Holders Of Xtant Medical Holdings, Inc.  Post Analyst - 20 hours ago Xtant Medical Holdings, Inc.  reached 106.31% versus a 1-year low price of $0.2851. The stock was last seen -10.7% lower, reaching at $0.6 on Mar. 21, 2017.Price Targets in Focus For AmpliPhi Biosciences Corporation  Xtant ... - Rives JournalZacks: Xtant Medical Holdings Inc  Given $2.75 Average Price Target by ... - The Cerbat Gem'
p7
aS'Investor Center: Technical Focus on Xtant Medical Holdings Inc.  Rives Journal - Mar 21, 2017 Xtant Medical Holdings Inc.  has a 14-day Commodity Channel Index  of 14.31. The CCI was designed to typically remain within the reading of -100 to +100.'
p8
aS'Xtant Medical Holdings Announces Uplisting to NYSE MKT GlobeNewswire  - Oct 15, 2015 BELGRADE, Mont., Oct. 15, 2015  -- Xtant Medical Holdings, Inc. , a leader in the development of regenerative medicine products and medical devices, today announced that its common stock has been approved for listing on the&nbsp;...'
p9
aS'Xtant Medical Holdings, Inc.  held by 5 SEC 13F Filers Post Analyst - Mar 17, 2017 Xtant Medical Holdings, Inc.  reached 80.69% versus a 1-year low price of $0.285. The stock was last seen 11.02% higher, reaching at $0.52 on March 16, 2017.'
p10
a.